J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colvin, P. L.
Right arrow Articles by Rudel, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colvin, P. L.
Right arrow Articles by Rudel, L. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 40, 1782-1792, October 1999
Copyright © 1999 by Lipid Research, Inc.


Original Article

Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates

Perry L. Colvinb, Emilio Moriguchia, P. Hugh R. Barrettc, John S. Parksa, and Lawrence L. Rudela
a Department of Pathology (Comparative Medicine), Wake Forest University School of Medicine, Winston-Salem, NC 27157
b Department of Internal Medicine and Division of Gerontology, University of Maryland School of Medicine and the Baltimore Veterans Affairs Medical Center Geriatrics Research, Education, and Clinical Center, Baltimore, MD 21201
c Department of Bioengineering, University of Washington, Seattle, WA 98195

Correspondence to: Perry L. Colvin

We hypothesized that small HDL particles, containing two apoA-I molecules but no apoA-II (LpAI), may be converted in vivo into medium and large HDL particles, containing three or four apoA-I molecules, respectively, and that more conversion will occur in animals with higher HDL concentrations. To test this possibility, kinetic studies of small LpAI were performed in African green monkeys with either high plasma HDL cholesterol concentrations (120 ± 36 mg/dl, mean ± SD, n = 3) or low plasma HDL cholesterol concentrations (40 ± 13 mg/dl, n = 3). Tracer small LpAI was purified, without ultracentrifugation, by immunoaffinity and gel filtration. After injection, the specific activity of apoA-I in small, medium, and large HDL, consisting of both LpAI and LpAI:AII particles, was followed. A multicompartmental model was developed with the simultaneous analysis of urine and plasma turnover data for the kinetics of apoA-I in small, medium, and large HDL. These analyses indicated that small HDL is converted to either medium or large HDL with little or no interconversion of medium HDL and large HDL. Much of the metabolic conversion of small HDL occurs in a sequestered pool, effectively outside the circulating plasma, in a unidirectional manner before reentering the circulating plasma as medium or large HDL. The mean fractional catabolic rate of apoA-I in small, medium, and large HDL was not different comparing the high and low HDL group. In contrast, the mean production rate of apoA-I was greater in the high HDL group compared with the low HDL group.

These data support the hypothesis that the plasma concentration of HDL is primarily a function of the rate of appearance of apoA-I in medium and large HDL.—Colvin, P. L., E. Moriguchi, P. H. R. Barrett, J. S. Parks, and L. L. Rudel. Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates. J. Lipid Res. 1999. 40: 1782;–1792.

Supplementary key words: apoA-I, apoA-II, cholesterol, high density lipoproteins, kinetic model, LpAI, LpAI:AII, nonhuman primates, metabolic turnover


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
J.-Y. Lee, J. M. Timmins, A. Mulya, T. L. Smith, Y. Zhu, E. M. Rubin, J. W. Chisholm, P. L. Colvin, and J. S. Parks
HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney
J. Lipid Res., October 1, 2005; 46(10): 2233 - 2245.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. C. de Beer, D. van der Westhuyzen, N. L. Whitaker, N. R. Webb, and F. C. de Beer
SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
J. Lipid Res., October 1, 2005; 46(10): 2143 - 2150.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. M. Wallace, M. Schwarz, P. Coward, J. Houze, J. K. Sawyer, K. L. Kelley, A. Chai, and L. L. Rudel
Effects of peroxisome proliferator-activated receptor {alpha}/{delta} agonists on HDL-cholesterol in vervet monkeys
J. Lipid Res., May 1, 2005; 46(5): 1009 - 1016.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J.-Y. Lee, L. Lanningham-Foster, E. Y. Boudyguina, T. L. Smith, E. R. Young, P. L. Colvin, M. J. Thomas, and J. S. Parks
Pre{beta} high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice
J. Lipid Res., April 1, 2004; 45(4): 716 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Okubo, K. Ikewaki, S. Sakai, N. Tada, Y. Kawaguchi, and S. Mochizuki
Abnormal HDL Apolipoprotein A-I and A-II Kinetics in Hemodialysis Patients: A Stable Isotope Study
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1008 - 1015.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. C. Cheung, S. D. Sibley, J. P. Palmer, J. F. Oram, and J. D. Brunzell
Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II)
J. Lipid Res., August 1, 2003; 44(8): 1552 - 1558.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. R. Webb, L. Cai, K. S. Ziemba, J. Yu, M. S. Kindy, D. R. van der Westhuyzen, and F. C. de Beer
The fate of HDL particles in vivo after SR-BI-mediated selective lipid uptake
J. Lipid Res., November 1, 2002; 43(11): 1890 - 1898.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Kee, K.-A. Rye, J. L. Taylor, P. H. R. Barrett, and P. J. Barter
Metabolism of ApoA-I as Lipid-Free Protein or as Component of Discoidal and Spherical Reconstituted HDLs: Studies in Wild-Type and Hepatic Lipase Transgenic Rabbits
Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1912 - 1917.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. W. Chisholm, E. R. Burleson, G. S. Shelness, and J. S. Parks
ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL
J. Lipid Res., January 1, 2002; 43(1): 36 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. W. Huggins, P. L. Colvin, E. R. Burleson, K. Kelley, J. K. Sawyer, P. H. R. Barrett, L. L. Rudel, and J. S. Parks
Dietary n-3 polyunsaturated fat increases the fractional catabolic rate of medium-sized HDL particles in African green monkeys
J. Lipid Res., September 1, 2001; 42(9): 1457 - 1466.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. W. Huggins, E. R. Burleson, J. K. Sawyer, K. Kelly, L. L. Rudel, and J. S. Parks
Determination of the tissue sites responsible for the catabolism of large high density lipoprotein in the African green monkey
J. Lipid Res., March 1, 2000; 41(3): 384 - 394.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.